Otros idiomas Oxford Biomedica plc

Acciones

Tiempo real estimado Cboe Europe Otros sitios de cotización 09:32:42 02/05/2024			Varia. Cinco días.	Varia. 1 de enero.
285,8 ^GBX	-0,44 %		+31,98 %	+28,98 %

29/04	El FTSE 100, pendiente de la decisión de la Fed sobre los tipos de interés	AN
29/04	Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024

FTSE 100 as investors look to Fed rate decision	29/04
Oxford Biomedica : Preliminary results for the year ended 31 December 2023 29 April 2024	29/04
Oxford BioMedica bullish; Petrofac slumps	29/04
Earnings Flash (OXB.L) OXFORD BIOMEDICA Reports FY23 Revenue GBP89.5M	29/04
Oxford Biomedica plc Reiterates Earnings Guidance for the Year 2024	29/04
Oxford Biomedica plc Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
HSBC likes Haleon, cuts Flutter to 'hold'	18/04
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	20/03
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs	20/03
Oxford Biomedica plc Announces Board Changes	11/03
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract	05/03
Update to Medium-Term Financial Guidance and 2023 Trading and Notice of Preliminary Results	05/03
Oxford Biomedica plc Provides Earnings Guidance for the Year Ended December 31, 2023 and for the Fiscal Year 2024	05/03
Barclays cuts Bank of Ireland to 'equal weight'	05/03
EnSilica hires new chief financial officer from Oxford Biomedica	05/02
EnSilica Appoints Oxford Biomedica Executive as CFO	05/02
Oxford Biomedica Completes EUR15 Million ABL Europe Acquisition	29/01
Institut Merieux ups stake in Oxford BioMedica toward 10%	29/01
Oxford Biomedica completes acquisition of ABL Europe	29/01
Oxford Biomedica plc completed the acquisition of additional 3.2% stake in ABL EUROPE S.A.S. from TSGH ?6.1 million	29/01

No hay resultados para esta búsqueda